Compugen Ltd. (CGEN) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the ComputeGen LTD Second Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. An audio webcast of this call is available in the Investments section of ComputeGen's website www .cgen.com. As a reminder, today's call is being recorded. I would now like to introduce Yvonne Mocklin, Vice President, Head of Investor Relations and Corporate Communications. Thank you, Operator, and thank you all for joining us on the call today. Joining me from ComputeGen is Dr. Anath Kholen-Diark, Head of the Chief Executive Officer, and David Sivaman, Chief Financial Officer. Dr. Michelle Morer, Chief Medical Officer, and Dr. Alana Lofair, Chief Scientific Officer, will join us with the Q&A. Before we begin, we would like to remind you that during this call, the company will make projections of forward-looking statements regarding future events, business outlook, development efforts and their potential outcome, the company's discovery platform, anticipated progress and plans, results and timelines for our programs, financial and accounting related matters, as well as statements regarding our cash petition and cash runway. We reached a call from you that said statements reflect only the company's current release, expectations and assumptions, but actual results, performance, or achievements of the company in a different material. These statements are subject to known and unknown lists and uncertainties, and we refer you to our SEC filing for more details on these lists, including the company's most recent annual report on forms for NTS. The company undertakes no obligation to update projections and forward-looking statements in the future. With that, I turn the call over to Anath. Thank you, John, and a warm welcome to everyo...